Ion Beam Applications SA
Marc Van der Burght has over 20 years of work experience. Marc started their career at Tractebel Development as a Project Engineer in 1991 and worked there until 2002. Marc then joined Ion Beam Applications and held various roles, including Project Manager from 2002 to 2009, Vice President Particle Therapy Operations from 2009 to 2012, and Vice President Equipment & Service Delivery from 2012 to the present. In 2019, they became the Chief Operations Officer at Ion Beam Application.
Marc Van der Burght attended the Université catholique de Louvain from 1986 to 1991, where they pursued a degree in Mechanical Engineering.
This person is not in any teams
Ion Beam Applications SA
4 followers
Ion Beam Applications SA (IBA) is a Belgium-based company that develops and markets technologies, pharmaceutical products and tailored solutions for the healthcare sector, with emphasis on cancer diagnosis and therapy. IBA is also active in the sterilization and ionization field. The Company operates through two business segments, namely the pharmaceuticals segment, which includes radiopharmaceuticals and the equipments segment, which encompasses proton therapy, particle accelerators and dosimetry. Through its various subsidiaries, Ion Beam Applications SA is active in a number of countries, including Belgium, Germany, France, Italy, Spain, the United Kingdom, Sweden, the United States, India and China. In November 2013, the Company announced the closing of the sale of 100% of its business unit Cisbio Bioassays.